Dr. Martens (DOCS) Stock Forecast & Price Target

GBX 56.25 -1.85 (-3.18%)

As of 05/21/2025 11:53 AM Eastern

Dr. Martens - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 1 Analyst Ratings

Sell
0

Hold
1

Buy
0

Based on 1 Wall Street analysts who have issued ratings for Dr. Martens in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for DOCS.

Consensus Price Target

GBX 6,000

According to the 1 analysts' twelve-month price targets for Dr. Martens, the average price target is GBX 6,000. The highest price target for DOCS is GBX 6,000, while the lowest price target for DOCS is GBX 6,000. The average price target represents a forecasted upside of 10,566.67% from the current price of GBX 56.25.

Get the Latest News and Ratings for DOCS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Dr. Martens and its competitors.

DOCS Analyst Ratings Over Time

Type	Current Forecast 5/22/24 to 5/22/25	1 Month Ago 4/22/24 to 4/22/25	3 Months Ago 2/22/24 to 2/21/25	1 Year Ago 5/23/23 to 5/22/24
Strong Buy	0 Strong Buy rating(s)	N/A	N/A	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	N/A	N/A	1 Buy rating(s)
Hold	1 Hold rating(s)	N/A	N/A	1 Hold rating(s)
Sell	0 Sell rating(s)	N/A	N/A	0 Sell rating(s)
Consensus Price Target	GBX 6,000	N/A	N/A	GBX 177.50
Consensus Rating	Hold	N/A	N/A	Moderate Buy

DOCS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DOCS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Dr. Martens Stock vs. The Competition

Type	Dr. Martens	Consumer Cyclical Companies
Consensus Rating Score	2.00	2.60
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Neutral News See Recent DOCS News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
5/19/2025	Royal Bank of Canada 3 of 5 stars		Lower Target	Sector perform	GBX 7,000 ➝ GBX 6,000	+10,298.61%
6/5/2023	Barclays 3 of 5 stars		Reiterated Rating	Overweight	GBX 175	+30.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:36 AM ET.

DOCS Forecast - Frequently Asked Questions

: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Dr. Martens is GBX 6,000, with a high forecast of GBX 6,000 and a low forecast of GBX 6,000.
: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
: According to analysts, Dr. Martens's stock has a predicted upside of 10,566.67% based on their 12-month stock forecasts.
: Dr. Martens has been rated by research analysts at Royal Bank of Canada in the past 90 days.
: Analysts like Dr. Martens less than other "consumer cyclical" companies. The consensus rating for Dr. Martens is Hold while the average consensus rating for "consumer cyclical" companies is Moderate Buy. Learn more on how DOCS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (LON:DOCS) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dr. Martens (DOCS) Stock Forecast & Price Target